1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
(
- Contribution to journal › Article
- 2017
-
Mark
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy
(
- Contribution to journal › Article